Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patient
- 1 July 1992
- journal article
- Published by SAGE Publications in Palliative Medicine
- Vol. 6 (3), 257-259
- https://doi.org/10.1177/026921639200600311
Abstract
A patient is described whose output from an enterocutaneous fistula was greatly reduced using octreotide, a somatostatin analogue.Keywords
This publication has 8 references indexed in Scilit:
- Short Bowel SyndromeDigestion, 1990
- Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.Gut, 1989
- BLIND EVALUATION OF THE EFFECT OF OCTREOTIDE (SMS 201-995), A SOMATOSTATIN ANALOGUE, ON SMALL-BOWEL FISTULA OUTPUTThe Lancet, 1987
- Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of SomatostatinScandinavian Journal of Gastroenterology, 1986
- Effects of Cimetidine on Jejunostomy Effluents in Patients with Severe Short-Bowel SyndromeScandinavian Journal of Gastroenterology, 1986
- SomatostatinNew England Journal of Medicine, 1983
- Somatostatin Suppresses Secretin and Pancreatic Exocrine SecretionScience, 1975
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974